- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2197-7364
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Tissue dose estimation after extravasation of 177Lu-DOTATATE ; volume:8 ; number:1 ; day:31 ; month:3 ; year:2021 ; pages:1-15 ; date:12.2021
EJNMMI Physics ; 8, Heft 1 (31.3.2021), 1-15, 12.2021
- Creator
-
Tylski, Perrine
Pina-Jomir, Géraldine
Bournaud-Salinas, Claire
Jalade, Patrice
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-021-00378-3
- URN
-
urn:nbn:de:101:1-2021051619314842926667
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tylski, Perrine
- Pina-Jomir, Géraldine
- Bournaud-Salinas, Claire
- Jalade, Patrice
- SpringerLink (Online service)
Other Objects (12)
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report
Less is sometimes more – Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96 h
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report
Less is sometimes more – Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96 h
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie
Accuracy and precision assessment for activity quantification in individualized dosimetry of 177Lu-DOTATATE therapy
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
Dose mapping after endoradiotherapy with 177Lu-DOTATATE/DOTATOC by a single measurement after 4 days
p53 stabilisation potentiates [177Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
SPECT image segmentation for estimation of tumour volume and activity concentration in 177Lu-DOTATATE radionuclide therapy
Impact of cyclic changes in pharmacokinetics and absorbed dose in pediatric neuroblastoma patients receiving [177Lu]Lu-DOTATATE
Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
Dosimetric implications of kidney anatomical volume changes in 177Lu-DOTATATE therapy
Lymphopenia during 177Lu-DOTATATE therapy leading to recurrence of tuberculosis: a case report
Less is sometimes more – Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96 h
Einfluss der Peptid-Radio-Rezeptor-Therapie mittels 90Y- und 177Lu-DOTATATE auf die inflammatorische Atheroskleroseaktivität : Therapiemonitoring mittels serieller 68Ga-DOTATATE Positronenemissionstomographie, Computertomographie